Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QuinFoi is a combination nutritional supplement developed by Zealina Life Sciences, primarily indicated for use in obstetric and gynecological care. It contains three essential B-vitamins in their bioactive forms: levomefolate calcium (L-methylfolate), methylcobalamin (Vitamin B12), and pyridoxal 5-phosphate (Vitamin B6). This combination is designed to support healthy pregnancy outcomes by providing the necessary cofactors for DNA synthesis, red blood cell formation, and the regulation of homocysteine levels. By utilizing the active forms of these vitamins, QuinFoi ensures optimal bioavailability, particularly in individuals with genetic variations that impair the metabolism of synthetic vitamins, such as MTHFR polymorphisms. It is commonly used for the prevention of neural tube defects, management of pregnancy-induced anemia, and treatment of hyperhomocysteinemia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on QuinFoi.